153 related articles for article (PubMed ID: 9102073)
1. [Active forms of oxygen and pathogenesis of rheumatoid arthritis and systemic lupus erythematosus].
Lisitsyna TA; Ivanova MM; Durnev AD
Vestn Ross Akad Med Nauk; 1996; (12):15-20. PubMed ID: 9102073
[TBL] [Abstract][Full Text] [Related]
2. [The role of the PD-1 protein in pathogenesis of autoimmune diseases, with particular consideration of rheumatoid arthritis and systemic lupus erythematosus].
Siwiec A; Majdan M
Postepy Hig Med Dosw (Online); 2015 Apr; 69():534-42. PubMed ID: 25983292
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus.
Mansour RB; Lassoued S; Gargouri B; El Gaïd A; Attia H; Fakhfakh F
Scand J Rheumatol; 2008; 37(2):103-8. PubMed ID: 18415766
[TBL] [Abstract][Full Text] [Related]
4. Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease?
Griffiths HR
Autoimmun Rev; 2008 Jul; 7(7):544-9. PubMed ID: 18625443
[TBL] [Abstract][Full Text] [Related]
5. The significance of antibodies to poly(adenosine diphosphate-ribose) in systemic lupus erythematosus.
Okolie EE; Shall S
Clin Exp Immunol; 1979 Apr; 36(1):151-64. PubMed ID: 313859
[TBL] [Abstract][Full Text] [Related]
6. Tobacco smoking and autoimmune rheumatic diseases.
Harel-Meir M; Sherer Y; Shoenfeld Y
Nat Clin Pract Rheumatol; 2007 Dec; 3(12):707-15. PubMed ID: 18037930
[TBL] [Abstract][Full Text] [Related]
7. Specific and shared idiotypes found on hybridoma anti-DNA autoantibodies derived from rheumatoid arthritis and systemic lupus erythematosus patients.
Rauch J; Massicotte H; Tannenbaum H
J Immunol; 1985 Oct; 135(4):2385-92. PubMed ID: 3875652
[TBL] [Abstract][Full Text] [Related]
8. [Peculiarities of free radical and antioxidant statute in patients with systemic lupus erythematosus and rheumatoid arthritis].
Podoprigorova VG; Bobylev AA; Ivanova SM; Speranskiĭ AI
Biomed Khim; 2005; 51(5):536-41. PubMed ID: 16342671
[TBL] [Abstract][Full Text] [Related]
9. Possible role of adipokines in systemic lupus erythematosus and rheumatoid arthritis.
Barbosa Vde S; Rêgo J; Antônio da Silva N
Rev Bras Reumatol; 2012; 52(2):278-87. PubMed ID: 22460416
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against galectin-8: their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation.
Massardo L; Metz C; Pardo E; Mezzano V; Babul M; Jarpa E; Guzmán AM; André S; Kaltner H; Gabius HJ; Jacobelli S; González A; Soza A
Lupus; 2009 May; 18(6):539-46. PubMed ID: 19395456
[TBL] [Abstract][Full Text] [Related]
11. Therapeutics to block autoantibody initiation and propagation in systemic lupus erythematosus and rheumatoid arthritis.
Suurmond J; Zou YR; Kim SJ; Diamond B
Sci Transl Med; 2015 Mar; 7(280):280ps5. PubMed ID: 25810309
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
Khan F; Siddiqui AA
Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
[TBL] [Abstract][Full Text] [Related]
13. Oxidative Stress in Autoimmune Diseases: An Under Dealt Malice.
Ramani S; Pathak A; Dalal V; Paul A; Biswas S
Curr Protein Pept Sci; 2020; 21(6):611-621. PubMed ID: 32056521
[TBL] [Abstract][Full Text] [Related]
14. Early environmental exposure and the development of lupus.
Edwards CJ; Cooper C
Lupus; 2006; 15(11):814-9. PubMed ID: 17153856
[TBL] [Abstract][Full Text] [Related]
15. Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis.
Shah D; Wanchu A; Bhatnagar A
Immunobiology; 2011 Sep; 216(9):1010-7. PubMed ID: 21601309
[TBL] [Abstract][Full Text] [Related]
16. Differential generation of chemiluminescence--detectable oxygen radicals by normal polymorphonuclear leukocytes challenged with sera from systemic lupus erythematosus and rheumatoid arthritis patients.
D'Onofrio C; Maly FE; Fischer H; Maas D
Klin Wochenschr; 1984 Aug; 62(15):710-6. PubMed ID: 6492692
[TBL] [Abstract][Full Text] [Related]
17. Free radical mediated peroxidative damage in systemic lupus erythematosus.
Kurien BT; Scofield RH
Life Sci; 2003 Aug; 73(13):1655-66. PubMed ID: 12875898
[TBL] [Abstract][Full Text] [Related]
18. [Importance of the determination of antibodies to n-DNA in systemic lupus erythematosus and other rheumatic diseases (comparative study of radioisotope and immunoenzyme technics)].
Riazantseva TA; Shakhanina KL; Aroian AA; Speranskiĭ AI
Ter Arkh; 1987; 59(8):86-91. PubMed ID: 3317973
[TBL] [Abstract][Full Text] [Related]
19. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.
Dejica DI; Manea EM
Roum Arch Microbiol Immunol; 2006; 65(1-2):66-74. PubMed ID: 17877113
[TBL] [Abstract][Full Text] [Related]
20. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
